Intravascular Blood Pump

Spectroscopy-based sensors in intravascular blood pumps enable accurate positioning and cardiac recovery monitoring, addressing placement challenges and improving treatment efficacy through tissue and blood analysis.

JP2024542722APending Publication Date: 2024-11-15ABIOMED INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2024532682
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-12-23
Filing Date
2022-12-02
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

Existing intravascular blood pumps lack effective methods for accurately positioning within the heart and assessing cardiac recovery, relying on manual placement and limited sensor data for tissue identification and health monitoring.

Method used

Incorporation of spectroscopy-based sensors to detect and characterize tissue types, determine appropriate positioning, and monitor cardiac recovery by analyzing spectral responses of tissue and blood properties, using machine learning for data analysis and treatment plan recommendations.

Benefits of technology

Enhances precise positioning of intravascular blood pumps and provides real-time assessment of cardiac recovery, enabling informed treatment decisions based on tissue and blood characteristics.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024542722000001_ABST
    Figure 2024542722000001_ABST
Patent Text Reader

Abstract

Techniques and systems can be provided for using spectroscopy-based and / or image-based sensing with an intravascular blood pump. The techniques generally include capturing a spectral response of the measured tissue and / or blood to light. Based on a given need, the method can include, for example, determining a type of the measured tissue based on the spectral response, determining whether the measured tissue type matches a target tissue type, determining a health state of the measured tissue based on the spectral response, determining a treatment plan based on the health state of the measured tissue, determining the type and / or amount of components and / or properties in the blood, and / or determining an extent of cardiac recovery based on the type and / or amount of components and / or properties in the blood.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] CROSS-REFERENCE TO RELATED APPLICATIONS This application claims priority to U.S. Provisional Patent Application No. 63 / 285,810, filed December 3, 2021, and U.S. Provisional Patent Application No. 63 / 293,241, filed December 23, 2021, each of which is incorporated by reference in its entirety into this specification.

[0002] Technical Field The present disclosure relates to blood pump assemblies, such as intravascular blood pump assemblies arranged to support flow within a patient's blood vessels, and in particular to devices and methods for installing such devices and monitoring a patient (e.g., the patient's vasculature) in which the devices are installed. [Background technology]

[0003] background Intravascular blood pumps can be introduced surgically or percutaneously into a patient's body and used to pump blood from one location in the heart or circulatory system to another location in the heart or circulatory system. For example, when deployed in the left heart, an intravascular blood pump can pump blood from the left ventricle of the heart to the aorta. Similarly, when deployed in the right heart, an intravascular blood pump can pump blood from the inferior vena cava to the pulmonary artery. Examples of such blood pumps include the Impella® family of devices (Abiomed, Inc., Danvers, MA).

[0004] The blood pump may have one or more sensors that measure the patient's vasculature. For example, an intravascular blood pump may include one or more optical sensors that measure the pressure in the patient's vasculature, particularly within the patient's ventricular chambers, which may be used to operate the blood pump and / or to assess the condition of the patient's heart. Summary of the Invention [Means for solving the problem]

[0005] overview In some embodiments, a method of positioning a medical device, such as an intravascular blood pump, within a patient is disclosed. In some embodiments, the method includes detecting a tissue type at a first location via a sensor on the medical device and determining whether the detected tissue type matches a target tissue type. If the determined tissue type and the target tissue type match, the method includes immobilizing the intravascular blood pump. If the determined tissue type and the target tissue type differ, the method includes moving the medical device to a second location and performing the detecting and determining steps again. As will be appreciated, the medical device can be moved to a third, fourth, fifth (or more) location and the detecting and determining steps are repeated until the target tissue type and the detected tissue type match.

[0006] In some embodiments, the detector includes a spectroscopy-based sensor and the method includes a method for spectroscopy-based sensing using intravascular blood, the method can include capturing a spectral response of the measured tissue to the light, determining a type of the measured tissue based on the spectral response, and determining whether the type of the measured tissue matches a target tissue type.

[0007] In some embodiments, capturing the spectral response of the measured tissue to the light can include illuminating the measured tissue via a sensor and sensing the reflected light (e.g., via a detector such as a spectrometer or an image detector). In some embodiments, the method can include adjusting a distance the intravascular blood pump is inserted into the patient's blood vessel and repeating the capturing, determining, and judging steps. In some embodiments, the method can include generating or otherwise indicating an indication when the determined type matches the target tissue type.

[0008] In some embodiments, the method can include determining a distance from the intravascular blood pump to a measured tissue having a target tissue type. In some methods, the method can include determining whether a distance from the intravascular blood pump to a measured / detected tissue having a target tissue type matches a target distance between the intravascular blood pump and the patient's vasculature. In some embodiments, the method can include adjusting a position of the intravascular blood pump relative to the measured tissue having the target tissue type and repeating the distance determining step until the intravascular blood pump is positioned at a commanded distance from the target tissue. In some embodiments, the type of measured tissue can be based on information from a first sensor and the distance from the intravascular blood pump to the measured tissue can be based on information from a second sensor, such as from a distance sensor.

[0009] In some embodiments, the method can include determining a health state of the measured tissue. In some embodiments, determining the health state of the measured tissue can include classifying the health state of the measured tissue into one or more categories from a list of categories (such as healthy, recovered, and damaged).

[0010] In some embodiments, the method may include suggesting a treatment plan based on the determined measured tissue health. In some embodiments, the method may include determining a treatment plan to be proposed. In some embodiments, the treatment plan may be based on a plurality of characteristics, the plurality of characteristics including characteristics of the measured tissue and / or blood of the patient. In some embodiments, the plurality of characteristics may include characteristics of the patient, such as characteristics of the patient's heart. In some embodiments, the measured tissue health may be determined by an evaluation system. The evaluation system may include a database of spectral responses of tissues having known tissue health. In some embodiments, determining the measured tissue health may include comparing the measured tissue spectral response to the spectral responses of tissues having known tissue health in the database. In some embodiments, determining the measured tissue health may include determining whether the spectral response has similarity to a first spectral response of a tissue having a first known tissue health above a threshold and has similarity to a second spectral response of a tissue having a second known tissue health above a threshold.

[0011] In some embodiments, the method can include suggesting a treatment plan, the treatment plan including re-examining the tissue health after a period of time if the spectral response has a similarity to a first spectral response of a tissue having a first known tissue health condition above a threshold and a similarity to a second spectral response of a tissue having a second known tissue health condition above a threshold.

[0012] In some embodiments, the method can include capturing an additional spectral response (e.g., to light) of blood (e.g., blood in and / or around the pump) and determining a characteristic of the blood based on the additional spectral response. In some embodiments, the characteristic of the blood can include an identity or type of at least one substance in the blood and a concentration of the at least one substance. In some embodiments, the characteristic of the blood can be blood oxygenation (which can be determined, for example, based on determining the absorption, transmittance, and / or reflectance of light by the blood). In some embodiments, the characteristic of the blood can be hemolysis. In some embodiments, the characteristic of the blood can be lactic acidosis. In some embodiments, the method can include generating an alert if the characteristic of the blood based on the additional spectral response has a value above (and / or below) a specified threshold. In some embodiments, the method can include determining a degree of cardiac recovery based on a plurality of characteristics of the blood based on the additional spectral response.

[0013] In some embodiments, the plurality of characteristics can include an identity or classification of at least one substance in the blood and a concentration of the at least one substance. In some embodiments, the method can include determining and proposing a treatment plan based on the degree of cardiac recovery. In some embodiments, determining the degree of cardiac recovery can include comparing the identity or type and concentration of one or more substances in the blood to values ​​from a database.

[0014] A method for using spectroscopy-based sensing in an intravascular blood pump can be provided. The method can include capturing a spectral response of a measured tissue (such as cardiac tissue) to light, determining a measured tissue health state based on the spectral response, determining a treatment plan based on the measured tissue health state, and proposing a treatment plan. In some embodiments, determining the measured tissue health state can be determined by an evaluation system. In some embodiments, the method can include detecting and measuring other components and / or characteristics of the patient. In some embodiments, detecting and measuring other components and / or characteristics can include shining light onto blood in and / or around the pump and detecting and analyzing light after reflection from components in the blood. In some embodiments, detecting and measuring other components and / or characteristics can include assessing hemolysis while the pump is in use. In some embodiments, detecting and measuring other components and / or characteristics can include determining a concentration of lactate. In some embodiments, generating an alert when a concentration of a component in the blood or a value of a blood characteristic is determined to be above and / or below a threshold value. In some embodiments, the method may include automatically formatting and incorporating the selected treatment plan or treatment steps into the patient's medical record.

[0015] A method of determining a degree of cardiac recovery may also be provided. The method may include illuminating blood in and / or around an intravascular blood pump with light, capturing a spectral response to the light, determining the type and / or amount of components and / or properties in the blood, and determining the degree of cardiac recovery based on the type and / or amount of components and / or properties in the blood. In some embodiments, the method may include generating an alert if the determination of cardiac recovery is above and / or below one or more thresholds, if the amount of one or more components is determined to be above and / or below one or more thresholds, if the properties in the blood are determined to be above and / or below one or more thresholds, or combinations thereof. In some embodiments, the method may include determining and suggesting a treatment plan based on the degree of cardiac recovery.

[0016] In yet another embodiment, a system can be provided that can include an intravascular blood pump, a sensor disposed in or on the intravascular blood pump, the sensor coupled to one or more processors, a light source, a spectrometer, or an image detector, and a non-transitory computer readable storage medium. The non-transitory computer readable storage medium can include instructions that, when executed by the one or more processors, cause the system to direct light from a light source through the sensor to a tissue to be measured in the patient's vasculature, sense a spectral response of the light of the measured tissue captured by the sensor using the spectrometer or image detector, determine a type of the measured tissue based on the spectral response, and determine whether the type of the measured tissue matches a target tissue type.

[0017] In some embodiments, the system can be configured to indicate to a user when the type matches a target tissue type. In some embodiments, the system can be configured to determine a distance from the intravascular blood pump to a measured tissue having a target tissue type. In some embodiments, the system can be configured to determine whether a distance from the intravascular blood pump to a measured tissue having a target tissue type matches a target distance. In some embodiments, the system can be configured to determine a health state of the measured tissue. In some embodiments, the system can be configured to classify the health state of the measured tissue into one or more categories from a list of categories (e.g., healthy, restored, and / or damaged). In some embodiments, the system can be configured to determine and suggest a treatment plan based on the determined health state of the measured tissue. In some embodiments, the treatment plan can be determined based on a plurality of characteristics, the plurality of characteristics including characteristics of the patient's measured tissue and / or blood. In some embodiments, the plurality of characteristics including characteristics of the patient and / or the patient's heart.

[0018] In some embodiments, the system can include a database operably coupled to the one or more processors. In some embodiments, the system can be configured to compare the measured tissue spectral response to the spectral responses of tissues with known tissue health conditions in the database. In some embodiments, the system can be configured to determine whether the spectral response has similarity to a first spectral response of a tissue with a first known tissue health condition above a threshold and to a second spectral response of a tissue with a second known tissue health condition above a threshold. In some embodiments, the system can be configured to re-examine the tissue health after a period of time after determining that the spectral response has similarity to the first spectral response of a tissue with a first known tissue health condition above a threshold and to a second spectral response of a tissue with a second known tissue health condition above a threshold. In some embodiments, the system can be configured to capture an additional spectral response (e.g., to light) of the blood and determine a characteristic of the blood based on the additional spectral response. In some embodiments, the characteristic of the blood can include an identity or type of at least one substance in the blood and a concentration of at least one substance. In some embodiments, the characteristic of the blood can be blood oxygenation. In some embodiments, the system can be configured to determine blood oxygenation based on determining the absorption, transmittance and / or reflection of light by blood. In some embodiments, the characteristic of blood can be hemolysis. In some embodiments, the characteristic of blood can be lactic acidosis. In some embodiments, the system can be configured to generate an alert when the characteristic of blood based on the additional spectral response has a value below a threshold.

[0019] In some embodiments, the system can be configured to determine the degree of cardiac recovery based on a plurality of characteristics of the blood based on the additional spectral response. In some embodiments, the plurality of characteristics includes an identification or classification of at least one substance in the blood and a concentration of at least one substance. In some embodiments, the system can be configured to determine and suggest a treatment plan based on the degree of cardiac recovery. In some embodiments, the system can be configured to determine the degree of cardiac recovery by comparing the identification or type and concentration of one or more substances in the blood to values ​​from a database.

[0020] BRIEF DESCRIPTION OF THE DRAWINGS The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate embodiments of the present disclosure and, together with the general description of the disclosure given above and the detailed description of the embodiments given below, serve to explain the principles of the disclosure. [Brief description of the drawings]

[0021] [Figure 1] FIG. 1 is a diagram of a blood pump positioned through the aorta, extending through the aortic valve into the left ventricle, and having an integrated pressure sensor. [Diagram 2] FIG. 1 illustrates a side cross-sectional view of one embodiment of a sensor interacting with tissue. [Diagram 3] 1 is a flow chart of one embodiment of the disclosed method. [Figure 4] 1 is a flow chart of another embodiment of the disclosed method. [Diagram 5] 1 is a flow chart of another embodiment of the disclosed method. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0022] Detailed Description The following description and drawings exemplify the principles of the present disclosure. Thus, it will be understood that those skilled in the art can devise various arrangements that embody and fall within the scope of the principles of the present disclosure, although not explicitly described or illustrated herein. Furthermore, all examples listed herein are intended for illustrative purposes to help the reader understand the principles of the present disclosure and the concepts that the inventors contribute to promoting the art, and should be construed as not being limited to such specifically listed examples and conditions. Furthermore, the term "or" as used herein refers to a non-exclusive or, unless otherwise indicated (e.g., "otherwise" or "or in the alternative"). Also, the various embodiments described herein are not necessarily mutually exclusive, since some embodiments can be combined with one or more other embodiments to form new embodiments.

[0023] Many of the innovative teachings of the present application are described with particular reference to presently preferred exemplary embodiments. However, it should be understood that this class of embodiments provides only a few examples of the many advantageous uses of the innovative teachings herein. In general, statements in the specification of the present application do not necessarily limit any of the various embodiments claimed. Moreover, some statements may apply to some inventive features but not to other features. Those skilled in the art informed by the teachings herein will appreciate that the present disclosure is applicable to a variety of other technical fields or embodiments.

[0024] Various embodiments relate to intravascular blood pumps. As is known, an intravascular blood pump can be surgically or percutaneously introduced into a patient's body to pump blood from one location in the heart or circulatory system to another location in the heart or circulatory system. For example, when deployed in the left heart, an intravascular blood pump can pump blood from the left ventricle of the heart into the aorta. Similarly, when deployed in the right heart, an intravascular blood pump can pump blood from the inferior vena cava to the pulmonary artery. Optionally, such a blood pump can have one or more sensors, such as for monitoring the patient (e.g., the patient's vasculature).

[0025] As described herein, the inventors have recognized the advantages of medical devices, such as the disclosed percutaneous heart pump, having one or more sensors used to measure the types and properties of several types of tissues in the body. For example, in some embodiments herein, an intravascular blood pump can include one or more sensors (e.g., one or more spectroscopy-based sensors) configured to detect and identify different types of tissues at or near the intravascular blood pump. In some embodiments, spectroscopy-based sensing can be used to identify and characterize different types of tissues in and around the heart. In some embodiments, the sensor can include an optical sensor, such as a biophotonic sensor. In some embodiments, elastic scattering spectroscopy can be used to identify various types of tissues.

[0026] According to one aspect herein, the disclosed sensors (e.g., spectroscopy-based sensors) can be used to properly position an intravascular blood pump within the heart. For example, one or more sensors can be used to determine different types of tissues surrounding the sensor and pump, such as tissues in and around the heart (e.g., aorta, heart wall, valves, veins, etc.), to allow a clinician to determine a proper position of the pump relative to a desired tissue type when the percutaneous blood pump is placed within the patient's body. In one such example, the sensors can be used to identify venous tissue, arterial tissue, and cardiac tissue until the pump is positioned at or near the desired type of tissue. In some embodiments, sensed data from one or more sensors (e.g., spectroscopy-based sensors) can be used to determine proximity and / or contact with different tissues in and around the heart (e.g., aorta, vein, heart wall) to determine a proper position of the pump within the heart.

[0027] As will be appreciated, although spectroscopy-based sensing has been disclosed to detect and / or determine the desired type and / or proximity of tissue at or near the blood pump or sensors for properly positioning the blood pump within the patient's heart, in other embodiments, other suitable sensors may be used.

[0028] In some embodiments, the sensed data can be used alone or in combination with data obtained from one or more other sensors to properly position the pump within the heart. For example, sensed data from a tissue sensor (e.g., a spectroscopy-based sensor) can be combined with sensed proximity data (e.g., indicating the distance between the pump and any surrounding tissue) from another sensor to determine the appropriate distance between the desired tissue and the pump.

[0029] According to another aspect of the present disclosure, systems and methods can use spectroscopy-based sensing (or other suitable sensors) to assess and track cardiac recovery. For example, such sensors can be used to assess and track the progress of cardiac healing of cardiac tissue over time. In some embodiments, such sensors can be used to determine an appropriate duration of therapy and / or support by an intravascular blood pump. For example, in some embodiments, spectroscopy-based sensors can be used to determine the state of the cardiac tissue at the start of therapy and during support (e.g., at different times during support). In some embodiments, the sensed data can be used to suggest weaning off cardiac pump support when the state of the cardiac tissue reaches a cardiac tissue threshold indicative of cardiac tissue recovery.

[0030] As will be appreciated, in some embodiments, machine learning can be used to determine both the types and conditions of different tissues in and around the heart. For example, in some embodiments, the sensor can be configured to sense different types of known tissue samples (e.g., aorta, vein, heart wall) and / or different stages of heart tissue to obtain a knowledge base of samples. In such embodiments, the sensed data can include a spectral response to light.

[0031] According to another aspect, spectroscopy-based sensing can be used to assess and track cardiac recovery by measuring blood chemistry. For example, in some embodiments, a spectroscopy-based sensor can be arranged to measure one or more components (e.g., lactate, red blood cells, and / or anticoagulants) and / or one or more properties of blood (e.g., oxygenation and / or hemolysis). In such embodiments, the levels of one or more blood components and / or the properties of such components can be used to determine the extent of cardiac recovery. For example, in one embodiment, the levels can be used to infer and / or detect muscle fatigue, which can be used to assess the extent of cardiac recovery.

[0032] Turning now to the figures, Figure 1 shows an exemplary intravascular blood pump 1 having a catheter 10 that can be introduced into a patient's heart. For example, as shown in this figure, in some embodiments, the pump can be inserted retrogradely into the descending aorta 11. As is known, the descending aorta is a portion of the aorta that first ascends and then descends from the heart and has an aortic arch 14. At the beginning of the aorta 12 is the aortic valve 15 that connects the left ventricle 16 to the aorta 12, through which the intravascular blood pump can extend.

[0033] As will be appreciated, the blood pump can be inserted into other suitable parts of the body. For example, in some embodiments, the blood pump can be inserted into the right ventricle. In some embodiments, the blood pump can be inserted into the femoral artery or jugular vein.

[0034] As shown in FIG. 1, the intravascular blood pump 1 can include a rotary pumping device 50 having a pump section 52 (sometimes referred to herein simply as a "pump") fastened to and spaced axially from a distal end of a catheter hose 20. In some embodiments, the blood pump can include a motor section 51 operably coupled to the pump section. In some embodiments, the motor section can be positioned distally from the distal end of the catheter hose. In some embodiments, the motor section can be positioned proximally from the catheter hose and coupled to the pump section via a flexible drive shaft.

[0035] The intravascular blood pump may include a cannula 53 (which may be a flexible flow cannula) that projects distally from the inflow end of the pump section 52 and has a suction inlet 54 located at its end. Distal to the suction inlet 54 may be provided with a soft flexible tip 55, which may be configured, for example, as a "pigtail" or in a J-shape. Extending through the catheter hose 20 are various lines and devices that may be important for the operation of the pumping device 50.

[0036] In some embodiments, the pump may include optical fibers 28A, 28B, which are attached at their proximal ends to the evaluation device 100. These optical fibers 28A, 28B may each be part of an optical sensor (such as a pressure sensor), whose sensor head 30, 60 may be located near the suction inlet 54 on the one hand and externally on the housing of the pump section 52 on the other hand. Although FIG. 1 shows the sensor head 30 as being external to the blood pump, the sensor head may also be located inside the blood pump, preferably in the inflow cage, which has a lumen through its interior that defines the suction inlet 54. In such an embodiment, information (e.g., pressure information) may be transmitted by the sensor heads 30 and 60 to the evaluation device 100, where it may be converted into an electrical signal and displayed, for example, on the display screen 101.

[0037] As also shown in FIG. 1, the pump can include a sensor 110, such as a sensor disposed for spectroscopy-based sensing, as described herein. As shown in this figure, the sensor 110 can be disposed on the inlet 52 housing in some embodiments. The sensor can also be positioned on other suitable portions of the pump, such as on the flexible tip 55, the cannula 53, and / or the outlet 60 housing. As will be appreciated, in some embodiments, the pump can include only a single sensor (e.g., a spectroscopy-based sensor). However, in other embodiments, the pump can include two or more such sensors (e.g., both the sensor 110 and an additional sensor 111 disposed for spectroscopy-based sensing). When multiple sensors are used, two or more of the sensors can be located on the same portion of the pump (e.g., on the inlet housing) and / or on different portions of the pump (e.g., on the flexible tip and the inlet housing).

[0038] In some embodiments, light (e.g., white light) can be directed at a section of tissue 120 via a sensor, and the reflected light from the tissue is detected by the sensor and then analyzed by a detector 125, such as a spectrometer or image detector. A light source 126, which may be separate or may be part of the spectrometer or image detector, can be coupled to an evaluation device. As will be appreciated, the detected and measured intensity and wavelength of the reflected light can be correlated to the composition and texture of the surface from which they reflect.

[0039] 1, one or more fibers (e.g., first fiber 128) can extend between the sensor 110 and the evaluation device 100. In such embodiments, the optical fiber can enable spectroscopic sensing (e.g., by transmitting reflected light to a spectrometer or image detector). For example, in some embodiments, the distal end can include an aperture facet facing into the tissue and the proximal end can interface with a spectrometer.

[0040] With reference to FIG. 2, in some embodiments, one or more fibers (e.g., a first fiber 128) can be operably connected to a spectrometer or image detector, and one or more other fibers (e.g., a second fiber 129) can be operably connected to a light source. In some embodiments, a single first fiber is connected to a spectrometer or image detector, and multiple second fibers are connected to a light source. A distal end 112 of each fiber can be directed toward a portion of tissue 120, and light 131 from the second fiber can be directed toward the tissue such that at least a portion of the light reflects off the surface of the tissue. In some embodiments, light of one or more wavelengths (such as light of one or more visible wavelengths (generally, about 400 nm to 700 nm) and / or light of one or more infrared wavelengths (generally, about 700 nm to 1 mm)) can reflect off a surface 141 of a first layer 142 of tissue facing the sensor (which can be understood as a blood-tissue interface). In some embodiments, light of one or more wavelengths may transmit through the first layer and reflect from a surface 143 of a second layer 144 of tissue facing the sensor (which may be understood as a first layer-second layer interface), where the first layer is between the second layer and the sensor. In some embodiments, light of one or more wavelengths may transmit through the first and second layers and reflect from a surface 145 of a third layer 146 of tissue facing the sensor (which may be understood as a second layer-third layer interface), where the first and second layers are between the third layer and the sensor. Depending on the power, wavelength, etc., the light may continue to transmit through additional layers beyond the third layer and reflect from a surface beyond the third layer. Note that in some embodiments, the light may transmit through bodily fluids 140, such as blood, before interacting with the tissue.

[0041] After reflecting off the surface, at least a portion of the light transmitted from the light source enters the distal end of the first fiber and is then transmitted to a detector (eg, a spectrometer or an image detector).

[0042] The detector can then determine a spectral characteristic of the sample. The detector can, for example, determine the transmittance and / or reflectance of the sample. The detector can determine the absorbance of the sample.

[0043] "Spectral characteristics" as used herein may include characteristics such as broadband spectral profiles, peaks and absorption bands in a spectrum, and may include temporal characteristics. In some embodiments, the spectral characteristics of a sample may be used to determine the type and characteristics of the sample. Referring to FIG. 1, in some embodiments, one or more processors 102 coupled to the evaluation device may be used to perform the required analysis. As will be appreciated by those skilled in the art, the processor may be coupled to various other components 103, 104, such as memory, non-transitory computer-readable storage media, wired or wireless interfaces, as necessary to perform various functions.

[0044] In some embodiments, the type and characteristics of the sample can be determined by comparing the spectral values ​​or other spectral characteristics with those in a knowledge bank of known tissues and tissue characteristics, which may be present in a database coupled to the evaluation device. In some embodiments, a trained machine learning (ML) model can be used to classify the spectral characteristics and thereby determine the type and characteristics of the sample. For example, a spectrometer or image detector can send a spectral profile of the sample to a processor, which can then extract features of the profile, and a trained ML model can be used to determine the type and characteristics of the sample based on the extracted features.

[0045] In some embodiments, the type may include a simple binary determination of a particular desired type of tissue (e.g., whether the tissue sample is cardiac tissue or not). In some embodiments, the type may include a determination related to the category or location of the vessel that the sensor is detecting (e.g., cardiac, arterial, venous, etc.). In some embodiments, the characteristic may include one or more detected substances and / or one or more concentrations of the detected substances. In some embodiments, the characteristic may include whether what is detected is healthy tissue, healed tissue, or damaged tissue.

[0046] In some embodiments, the sensor may irradiate / shine light (e.g., white light, typically including wavelengths of about 380 nm to about 750 nm) that is not tissue-related and may include infrared (IR, typically including wavelengths of about 750 nm to about 1 mm) light, such as near-infrared (NIR, typically including wavelengths of about 750 nm to about 1.4 μm) light. For example, the light may illuminate blood within the vasculature in which the pump is located (e.g., within the ventricle). As disclosed herein, the transmitted and / or reflected light may be detected and analyzed by a detector, such as a spectrometer or an image detector. In some embodiments, the detected data may be used to determine the type and amount of components in the blood and / or the characteristics of the blood. In some embodiments, this information may be used to determine the degree of cardiac recovery.

[0047] Methods of using spectroscopy-based sensing with pumps can be provided. Figure 3 provides a flow chart illustrating one embodiment of such a method. As shown in this figure, method 200 can include capturing 210 a spectral response of a first tissue to light. In some embodiments, this can include illuminating the first tissue with light via a sensor and detecting the transmitted and / or reflected light (e.g., via a spectrometer or image detector).

[0048] The transmitted and / or reflected light (e.g., the sensed data) can then be analyzed to determine the type of the first tissue (220). As disclosed herein, in some embodiments, this can be done by comparing the sensed data to data stored in a database. As disclosed herein, in some embodiments, this can be done by extracting features from the sensed data and allowing a trained machine learning (ML) model to provide a decision.

[0049] The first tissue type can then be compared to a desired / target tissue type. For purposes herein, a desired tissue type can include a tissue type of a desired location of the pump in the body. In that regard, the determined tissue type of the first tissue can be used to determine the location of the pump in and around the heart. For example, with brief reference to FIG. 1, in some embodiments, sensed data from a first sensor (e.g., sensor 110) can be used to determine whether an inlet to the blood pump is located in the left ventricle (e.g., if the sensed data is indicative of cardiac tissue), and sensed data from a second sensor (e.g., additional sensor 111) can be used to determine whether an outlet is in the aorta (e.g., if the sensed data is indicative of aortic tissue).

[0050] In some embodiments, the frequency of the capturing 210, determining 220, and comparing 230 steps can be 1 Hz or greater. That is, the system can capture the spectral response from the transmitted light, determine the tissue type, and compare it to the desired tissue type in 1 second or less. In some embodiments, the frequency can be 1-60 Hz. In some embodiments, these steps can be performed automatically while the device is inserted. In some embodiments, these steps can be performed when (or while) the clinician manually requests them (e.g., by pressing a button or switch). In still other embodiments, the capturing frequency can include timed steps (e.g., every 1 second, every 3 seconds, every 5 seconds, every 30 seconds, etc.).

[0051] In some embodiments, if the determined tissue type of the first tissue matches the desired tissue type, the method can include generating an alert (243). In some embodiments, the alert can indicate that the pump is in place. In some embodiments, the alert can indicate that the clinician inserting the pump should be aware of a change. For example, with reference to FIG. 1, as the blood pump is inserted into the patient's body, it can pass through the aortic valve and enter the left ventricle. When cardiac tissue is first detected, an alert can be generated to inform the clinician that the blood pump is nearly in place. Or, in a different example, if the system is configured to distinguish the aortic arch from the descending aorta, the alert can be used to make the clinician aware that the pump is approaching the aortic valve (and placement within the heart).

[0052] In some embodiments, if the determined tissue type of the first tissue matches a desired tissue type (e.g., a tissue type at a desired location for the pump), the method can include having the clinician stop adjusting the position of the pump (240). In some embodiments, such a step can be in response to an alert to the clinician to stop advancing the pump. The clinician can then secure the pump in place (242).

[0053] In some embodiments, even if the desired tissue type of the first tissue matches the determined tissue type, the clinician can still adjust the position of the pump within the heart. For example, the pump can also include one or more proximity sensors (such as one of sensors 30, 60), which may be, for example, a distance sensor. As will be appreciated, in other embodiments, any suitable distance sensor can be used. For example, the distance sensor may be an IR distance sensor. The distance sensor may also be an ultrasonic distance sensor, a laser distance sensor (e.g., a LiDAR sensor and / or an LED time-of-flight (TOF) sensor).

[0054] A proximity sensor can be used to determine the position of the pump relative to the desired tissue type 244. In such an embodiment, the clinician can adjust / move the pump 246 until the desired tissue type and proximity of the pump to the desired tissue type are determined to be met 248, and then the pump can be secured in place 242.

[0055] In some embodiments, the frequency of updates to determine position may be 1 Hz or greater. In some embodiments, the frequency may be 1-60 Hz. The frequency may be time-based. In some embodiments, these steps may occur automatically while the device is inserted. In some embodiments, these steps may occur when (or while) the clinician manually requests them (e.g., by pressing a button or switch, etc.).

[0056] If the determined tissue type does not match that of the desired location of the pump, the clinician may adjust the location of the pump within the body (e.g., in and around the heart) 250. As above, an alert may be provided to warn the clinician that the pump is at or near the desired location.

[0057] As will be appreciated, the sensing and adjusting process can be repeated several times (or more) until the determined tissue type matches the desired tissue type (see dashed line in FIG. 3). At this point, the sensor can then capture the spectral response of the second tissue to the light and compare the tissue type of the second tissue to that of the desired tissue type. The pump may then be moved (or not moved) depending on whether the second tissue type is of the desired tissue type or not. As above, the clinician can still move the pump after the desired tissue type is reached, such as until a desired proximity to the tissue is reached (e.g., by using one or more proximity sensors).

[0058] 4 illustrates another method for using spectroscopy-based sensing with a pump. As shown in this figure, the method 300 can include capturing 210 a spectral response of the measured tissue to the light. In some embodiments, the tissue is cardiac tissue.

[0059] The method may then include determining 310 tissue health based on the spectral response. In some embodiments, this may include determining whether the tissue is healthy, healed, or damaged. In some embodiments, the assessment system may include a database of spectral responses of tissues with known tissue health (e.g., healthy, healed, and damaged). In such embodiments, determining tissue health may include comparing the spectral response of the measured tissue to the spectral responses of known tissues in the database for that tissue type. The method may also include extracting features from the spectral response and feeding the extracted features to a trained ML model to classify the tissue health of the measured tissue.

[0060] As discussed above, spectroscopy-based sensing methods can include sensing and measuring (320) other components and / or characteristics of the patient. For example, in some embodiments, light can be directed at the blood in and around the pump, and the transmitted and / or reflected light is sensed and analyzed (e.g., via a spectrometer or image detector). In such embodiments, the spectral readings can be used to determine the type and amount (e.g., concentration, absolute amount, relative amount, etc.) of some components and / or characteristics of the blood. In one embodiment, the sensor can be configured to determine the oxygenation of the blood (e.g., by looking at and comparing the light absorption, transmission, and / or reflectance of oxygenated blood versus non-oxygenated blood). In some embodiments, based solely on the compared absorption. In some embodiments, based solely on the compared transmission. In some embodiments, based solely on the compared reflectance.

[0061] The sensor may also be used to assess hemolysis while the pump is in use. For example, in some embodiments, the sensor may be capable of detecting a spectral response of disrupted red blood cells. For example, in some embodiments, the spectral response may include one or more features indicative of whole red blood cells and one or more features indicative of disrupted red blood cells. In some embodiments, the fiber optic sensor may be configured to provide information regarding the chemical composition of the blood using Raman spectroscopy.

[0062] In some embodiments, the sensor takes one or more spectral readings at or before the pump starts to rotate, and the evaluation device compares the spectral readings taken after the pump starts to rotate with the initial reading to determine if there has been any change. In this manner, the method can provide absolute and / or relative changes to the blood.

[0063] In yet other embodiments, the sensor may be configured to measure one or more components that may be indicative of muscle fatigue, such as lactate.

[0064] As can be appreciated, depending on the sensed data, the evaluation system and / or display can be configured to provide an alert (e.g., to a clinician) (325) if certain values ​​reach (or fall below) predetermined thresholds.

[0065] In some embodiments, the method may include determining 330 a treatment plan based, for example, on the determined tissue health status. Such determination may be performed by one or more processors and by an evaluation system that may include a trained ML model.

[0066] In some embodiments, the treatment plan may be based on other characteristics of the tissue and / or blood. For example, in some embodiments, the treatment plan may be based on the determined health of the tissue, as well as the concentration of certain substances in the blood (e.g., lactate, etc.) and / or the degree to which the spectral response matches that of "intact" or "healthy" tissue. As will be further appreciated, even if the tissue is determined to be a restored tissue, other characteristics of the patient (e.g., age, weight, BMI, etc.) and / or heart (e.g., pulse rate, left ventricular blood pressure, etc.) may suggest that treatment should continue.

[0067] For example, if the tissue is determined to be healed tissue, the assessment system can suggest that the clinician consider weaning the patient off the pump. As will be appreciated, if the determined tissue characteristics are determined to be damaged, the system can suggest maintaining support of the patient with the pump.

[0068] In some embodiments, the method may include recommending (340) the determined treatment plan, such as to a clinician via a display. The clinician may accept or reject the proposed plan. In some embodiments, multiple treatment plans may be proposed and the clinician may select a plan. In some embodiments, predetermined treatment steps may be proposed and the clinician may select one or more of the treatment steps.

[0069] In some embodiments, the accepted treatment plan and / or treatment steps may then be automatically formatted and incorporated (345) into the patient's medical record, which may be stored in one or more databases to which the evaluation device is operatively coupled.

[0070] Although described above as tissue having a single defined tissue health state, it will be appreciated that the tested cardiac tissue may have a spectral response corresponding to more than one tissue health state (e.g., both healed and damaged tissue). As above, in cases where the spectral response corresponds to tissue having more than one tissue health state, the evaluation system may be configured to suggest a treatment plan to retest after a period of time to recheck the tissue health state, or may be configured to automatically retest after a period of time.

[0071] 5 illustrates how such measurements can be used to determine the degree of cardiac recovery and suggest treatment plans. For example, as shown in this figure, method 400 can include illuminating (410) blood in / around the pump with light (e.g., light as disclosed herein, which may be visible wavelengths, NIR wavelengths, etc.) and capturing (420) a spectral response to the light.

[0072] The method can include determining 430 the type and / or amount of constituents and / or properties in the blood as disclosed herein. In some embodiments, the determination can be based on the spectral response. For example, determining the concentration of a given constituent, the degree of hemolysis, and / or blood oxygenation based on the spectral response (e.g., by comparing to a profile in a database and / or using a trained ML model to make such a determination). In some embodiments, one or more of the determinations can be made based on data received from other sensors (e.g., pressure sensors, pH sensors, distance sensors, etc.).

[0073] The method may also include determining 440 the extent of cardiac recovery based on the components and / or characteristics. For example, this may include determining the extent of cardiac recovery based on blood chemistry (e.g., based on the presence or amount of certain components, such as chemicals, in the blood).

[0074] The method may also include generating an alert (450) if a number of conditions are met. In some embodiments, an alert may be generated if a cardiac recovery determination is above (and / or below) one or more thresholds. In some embodiments, an alert may be generated if an amount of one or more constituents is determined to be above (and / or below) one or more thresholds. In some embodiments, an alert may be generated if a characteristic in the blood is determined to be above (and / or below) one or more thresholds.

[0075] Finally, the method can include determining (460) and recommending (470) a treatment plan. Such a plan can be determined via an evaluation system as disclosed herein. The determination can depend on the degree of cardiac recovery. In an exemplary embodiment, the method can include illuminating blood with light via a spectroscopy-based sensor, capturing and analyzing a spectral response to the light, determining an amount of lactate in the blood, inferring the degree of cardiac recovery based on the amount of lactate in the blood, and recommending a treatment plan, such as weaning the patient off the heart pump, if the level of lactate corresponds to a level of a recovered heart.

[0076] As will be appreciated, in some embodiments, the evaluation system can include a database that includes different stages of cardiac recovery and levels of different components that can correspond to each stage. In some embodiments, determining the stage of cardiac recovery can include comparing the types and amounts of various components in the blood with those in the database. In some embodiments, there can be two stages (e.g., an injured stage and a recovered stage). In other embodiments, there can be three or more stages, which can be based on different endpoints. For example, in one embodiment, the stages can use recovery endpoints (e.g., severe injury, moderate injury, minor injury, and recovery), while in another embodiment, the stages can use surgery endpoints (e.g., immediately after surgery, short recovery period, long recovery period, post recovery). In some embodiments, these levels may correspond to different levels of muscle fatigue, which can correspond to different stages of cardiac recovery. In some embodiments, a trained ML model can be used to determine the stage of cardiac recovery based on extracted features from the received sensor data. Depending on the determined level, the evaluation system can suggest a treatment plan.

[0077] The embodiments of the present disclosure are described in detail with reference to the figures in which like reference numbers identify similar or identical elements. It should be understood that the disclosed embodiments are merely examples of the present disclosure, which may be embodied in various forms. Well-known functions or structures are not described in detail to avoid obscuring the present disclosure in unnecessary detail. Therefore, certain structural and functional details disclosed herein should not be interpreted as limiting, but merely as a basis for claims and as a representative basis for teaching those skilled in the art to employ the present disclosure in various ways in substantially any appropriately detailed structure.

Claims

1. 1. A method for using spectroscopy-based sensing in an intravascular blood pump, comprising: (a) acquiring a spectral response of a measured tissue to light; (b) determining a type of the measured tissue based on the spectral response; and (c) determining whether the measured tissue type matches a target tissue type; The method includes:

2. The method of claim 1 , wherein acquiring the spectral response of the measured tissue to light comprises illuminating the measured tissue with light via a sensor and sensing reflected light.

3. The method of claim 2 , wherein the reflected light is detected via a spectrometer or an image detector.

4. 10. The method of claim 1, further comprising: (d) adjusting a distance the intravascular blood pump is inserted into the patient's blood vessel; and repeating steps (a)-(c).

5. The method of claim 4 , further comprising: (e) indicating to a user when the type matches the target tissue type.

6. 6. The method of claim 5, further comprising: (f) determining a distance from the intravascular blood pump to the measured tissue having the target tissue type.

7. 7. The method of claim 6, further comprising: (g) determining whether the distance from the intravascular blood pump to the measured tissue having the target tissue type matches a target distance.

8. 8. The method of claim 7, further comprising: (h) adjusting a position of the intravascular blood pump relative to the measured tissue having the target tissue type; and repeating steps (f)-(g).

9. 9. The method of claim 8, wherein the type of the measured tissue is based on information from a first sensor and the distance from the intravascular blood pump to the measured tissue is based on information from a second sensor.

10. The method of claim 1 , further comprising: (i) determining a health state of the measured tissue.

11. The method of claim 10 , wherein determining the health state of the measured tissue comprises classifying the health state of the measured tissue into one or more categories from a list of categories.

12. The method of claim 11 , wherein the list of categories includes healthy tissue, healed tissue, and damaged tissue.

13. The method of claim 10 , further comprising: (j) suggesting a treatment plan based on the determined health state of the measured tissue.

14. The method of claim 13 , further comprising: (k) determining the treatment plan.

15. The method of claim 14 , wherein the treatment plan is based on a plurality of characteristics, the plurality of characteristics including the measured tissue and / or blood characteristics of the patient.

16. The method of claim 15 , wherein the plurality of characteristics comprises characteristics of the patient and / or the patient's heart.

17. The method of claim 10 , wherein the health state of the measured tissue is determined by a characterization system, the characterization system including a database of spectral responses of tissues having known tissue health states.

18. 20. The method of claim 17, wherein determining the health state of the measured tissue comprises comparing the spectral response of the measured tissue to spectral responses of tissues having known tissue health states in the database.

19. 11. The method of claim 10, wherein determining the health state of the measured tissue comprises determining whether the spectral response has similarity to a first spectral response of tissue having a first known tissue health state above a threshold and similarity to a second spectral response of tissue having a second known tissue health state above the threshold.

20. 20. The method of claim 19, further comprising proposing a treatment plan, the treatment plan including re-examining tissue health after a period of time if the spectral response has a similarity to a first spectral response of a tissue having a first known tissue health state above a threshold and a similarity to a second spectral response of a tissue having a second known tissue health state above the threshold.

21. (m) incorporating an additional spectral response of blood to light; and (n) determining a characteristic of the blood based on the additional spectral response; and The method of claim 1 further comprising:

22. 22. The method of claim 21, wherein the characteristics of the blood include the identity or type of at least one substance in the blood and the concentration of the at least one substance.

23. 22. The method of claim 21, wherein the blood property is blood oxygenation.

24. 24. The method of claim 23, wherein the oxygenation of the blood is based on determining the absorption, transmittance and / or reflectance of the light by the blood.

25. 22. The method of claim 21, wherein the characteristic of blood is hemolysis.

26. 22. The method of claim 21, wherein the blood characteristic is lactic acidosis.

27. 22. The method of claim 21, further comprising: (o) generating an alert if the characteristic of blood based on the additional spectral response has a value below a threshold.

28. 22. The method of claim 21, further comprising: (p) determining a degree of cardiac recovery based on a plurality of characteristics of the blood based on the additional spectral responses.

29. 30. The method of claim 28, wherein the plurality of characteristics comprises an identity or classification of at least one substance in the blood and a concentration of the at least one substance.

30. 30. The method of claim 29, further comprising: (q) determining and suggesting a treatment plan based on the degree of cardiac recovery.

31. 30. The method of claim 28, wherein determining the extent of cardiac recovery comprises comparing the identity, or type and concentration, of one or more substances in the blood with values ​​from a database.

32. 1. A method for using spectroscopy-based sensing in an intravascular blood pump, comprising: capturing a spectral response of the measured tissue to light; determining a health state of the measured tissue based on the spectral response; and determining a treatment plan based on the measured health state of the tissue; and proposing said treatment plan; The method includes:

33. 33. The method of claim 32, wherein the measured tissue is cardiac tissue.

34. 33. The method of claim 32, wherein determining the health state of the measured tissue is determined by a rating system.

35. 33. The method of claim 32, further comprising sensing and measuring other components and / or characteristics of the patient.

36. 36. The method of claim 35, wherein detecting and measuring other components and / or properties comprises shining light onto blood in and / or around the pump and detecting and analyzing the light after reflection from components in the blood.

37. 36. The method of claim 35, wherein sensing and measuring other components and / or properties comprises assessing hemolysis while the pump is in use.

38. 36. The method of claim 35, wherein sensing and measuring other components and / or properties comprises determining a concentration of lactate.

39. 36. The method of claim 35, further comprising generating an alert if the concentration of the component in the blood or the value of the characteristic of the blood is determined to be below a threshold value.

40. 33. The method of claim 32, further comprising automatically formatting and incorporating the selected treatment plan or treatment steps into the patient's medical record.

41. 1. A method for determining the extent of cardiac recovery, comprising: irradiating blood in and / or around the intravascular blood pump with light; capturing a spectral response to said light; determining the type and / or amount of components and / or properties in said blood; determining a degree of cardiac recovery based on the type and / or amount of the components and / or properties in the blood; The method includes:

42. if the cardiac recovery determination is above and / or below one or more thresholds; If the amount of the one or more components is determined to be above and / or below one or more threshold values, the characteristic in the blood is determined to be above and / or below one or more threshold values; or In the case of combinations of these, 42. The method of claim 41, further comprising generating an alert.

43. 42. The method of claim 41, further comprising determining and suggesting a treatment plan based on the degree of cardiac recovery.

44. 1. A system comprising: An intravascular blood pump; a sensor disposed in or on the intravascular blood pump, the sensor operably coupled to one or more of a processor, a light source, and a detector; When executed by the one or more processors, the system comprises: directing light from the light source through the sensor to tissue of interest within the patient's vasculature; using the detector to sense a spectral response of the measured tissue light captured by the sensor; determining a type of the measured tissue based on the spectral response; determining whether said type of said measured tissue matches a target tissue type; a non-transitory computer readable storage medium containing instructions; A system comprising:

45. 45. The system of claim 44, wherein the detector is a spectrometer or an imaging detector.

46. 45. The system of claim 44, further comprising instructions that, when executed by the one or more processors, cause the system to indicate to a user when the type matches the target tissue type.

47. 47. The system of claim 46, further comprising instructions that, when executed by the one or more processors, cause the system to determine a distance from the intravascular blood pump to the measured tissue having the target tissue type.

48. 48. The system of claim 47, further comprising instructions that, when executed by the one or more processors, cause the system to determine whether a distance from the intravascular blood pump to the measured tissue having the target tissue type matches a target distance.

49. 48. The system of claim 47, further comprising a distance sensor.

50. 45. The system of claim 44, further comprising instructions that, when executed by the one or more processors, cause the system to determine a health state of the measured tissue.

51. 51. The system of claim 50, further comprising instructions that, when executed by the one or more processors, cause the system to classify the health state of the measured tissue into one or more categories from a list of categories.

52. 52. The system of claim 51, wherein the list of categories includes health, recovery, and damage.

53. 45. The system of claim 44, further comprising instructions that, when executed by the one or more processors, cause the system to determine and suggest a treatment plan based on the determined measured tissue health state.

54. 54. The system of claim 53, wherein the treatment plan is determined based on a plurality of characteristics, the plurality of characteristics including the measured tissue and / or blood characteristics of the patient.

55. 55. The system of claim 54, wherein the plurality of characteristics comprises characteristics of the patient and / or the patient's heart.

56. 54. The system of claim 53, further comprising a database operably coupled to the one or more processors.

57. 57. The system of claim 56, further comprising instructions that, when executed by the one or more processors, cause the system to compare the spectral response of the measured tissue with the spectral responses of tissues of known tissue health in the database.

58. 57. The system of claim 56, further comprising instructions that, when executed by the one or more processors, cause the system to determine whether the spectral response has similarity to a first spectral response of tissue having a first known tissue health condition above a threshold and similarity to a second spectral response of tissue having a second known tissue health condition above the threshold.

59. 59. The system of claim 58, further comprising instructions that, when executed by the one or more processors, cause the system to re-examine tissue health after a period of time after determining that the spectral response has similarity to a first spectral response of tissue having a first known tissue health condition above a threshold and similarity to a second spectral response of tissue having a second known tissue health condition above the threshold.

60. 45. The system of claim 44, further comprising instructions that, when executed by the one or more processors, cause the system to capture an additional spectral response of blood to light and determine a characteristic of the blood based on the additional spectral response.

61. 61. The system of claim 60, wherein the characteristics of the blood include an identity or type of at least one substance in the blood and a concentration of the at least one substance.

62. 61. The system of claim 60, wherein the blood characteristic is blood oxygenation.

63. 63. The system of claim 62, further comprising instructions that, when executed by the one or more processors, cause the system to determine oxygenation of the blood based on determining the absorption, transmittance and / or reflection of the light by the blood.

64. 61. The system of claim 60, wherein the characteristic of blood is hemolysis.

65. 61. The system of claim 60, wherein the blood characteristic is lactic acidosis.

66. 61. The system of claim 60, further comprising instructions that, when executed by the one or more processors, cause the system to generate an alert if the characteristic of the blood based on the additional spectral response has a value below a threshold.

67. 61. The system of claim 60, further comprising instructions that, when executed by the one or more processors, cause the system to determine an extent of cardiac recovery based on a plurality of characteristics of the blood based on the additional spectral response.

68. 68. The system of claim 67, wherein the plurality of characteristics comprises an identification or classification of at least one substance in the blood and a concentration of the at least one substance.

69. 68. The system of claim 67, further comprising instructions that, when executed by the one or more processors, cause the system to determine and suggest a treatment plan based on the degree of cardiac recovery.

70. 68. The system of claim 67, further comprising instructions that, when executed by the one or more processors, cause the system to determine the extent of cardiac recovery by comparing the identity or type and concentration of one or more substances in the blood with values ​​from a database.